Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Irinotecan 100mg/5ml solution for infusion vials
0801050Q0AAAAAA
|
Irinotecan hydrochloride | Irinotecan hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Irinotecan 300mg/15ml solution for infusion vials
0801050Q0AAACAC
|
Irinotecan hydrochloride | Irinotecan hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Irinotecan 40mg/2ml solution for infusion vials
0801050Q0AAABAB
|
Irinotecan hydrochloride | Irinotecan hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Irinotecan 500mg/25ml solution for infusion vials
0801050Q0AAADAD
|
Irinotecan hydrochloride | Irinotecan hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Irinotecan pegylated liposomal 43mg/10ml inf vials
0801050Q0AAAEAE
|
Irinotecan hydrochloride | Irinotecan hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Isovorin 175mg/17.5ml solution for injection vials
0801000U0BBABAB
|
Isovorin | Calcium levofolinate | Malignant Disease and Immunosuppression | No data available |
|
Isovorin 25mg/2.5ml solution for injection vials
0801000U0BBAAAA
|
Isovorin | Calcium levofolinate | Malignant Disease and Immunosuppression | No data available |
|
Ituxredi 100mg/10ml concentrate for inf vials
0802030F0BFABAB
|
Ituxredi | Rituximab | Malignant Disease and Immunosuppression | No data available |
|
Ituxredi 500mg/50ml concentrate for inf vials
0802030F0BFAAAA
|
Ituxredi | Rituximab | Malignant Disease and Immunosuppression | No data available |
|
Ixazomib 2.3mg capsules
0801050CCAAAAAA
|
Ixazomib | Ixazomib | Malignant Disease and Immunosuppression | No data available |
|
Ixazomib 3mg capsules
0801050CCAAABAB
|
Ixazomib | Ixazomib | Malignant Disease and Immunosuppression | No data available |
|
Ixazomib 4mg capsules
0801050CCAAACAC
|
Ixazomib | Ixazomib | Malignant Disease and Immunosuppression | No data available |
|
Jakavi 10mg tablets
0801050BIBBADAD
|
Jakavi | Ruxolitinib | Malignant Disease and Immunosuppression | No data available |
|
Jakavi 15mg tablets
0801050BIBBABAB
|
Jakavi | Ruxolitinib | Malignant Disease and Immunosuppression | No data available |
|
Jakavi 5mg tablets
0801050BIBBAAAA
|
Jakavi | Ruxolitinib | Malignant Disease and Immunosuppression | No data available |
|
Jaypirca 100mg tablets
0801050CYBBAAAA
|
Jaypirca | Pirtobrutinib | Malignant Disease and Immunosuppression | No data available |
|
Jaypirca 50mg tablets
0801050CYBBABAB
|
Jaypirca | Pirtobrutinib | Malignant Disease and Immunosuppression | No data available |
|
Kadcyla 100mg pdr for concentrate for inf vials
0801050ADBCAAAC
|
Kadcyla | Trastuzumab | Malignant Disease and Immunosuppression | No data available |
|
Kadcyla 160mg pdr for concentrate for inf vials
0801050ADBCABAD
|
Kadcyla | Trastuzumab | Malignant Disease and Immunosuppression | No data available |
|
Kanjinti 150mg pdr for concentrate for inf vials
0801050ADBFAAAA
|
Kanjinti | Trastuzumab | Malignant Disease and Immunosuppression | No data available |
|
Kanjinti 420mg pdr for concentrate for inf vials
0801050ADBFABAE
|
Kanjinti | Trastuzumab | Malignant Disease and Immunosuppression | No data available |
|
Kepivance 6.25mg powder for solution for injection vials
0801000W0BBAAAA
|
Kepivance | Palifermin | Malignant Disease and Immunosuppression | No data available |
|
Kesimpta Sensoready 20mg/0.4ml inj pre-filled pens
0802040BDBBAAAA
|
Kesimpta | Ofatumumab | Malignant Disease and Immunosuppression | No data available |
|
Keytruda 100mg/4ml concentrate for inf vials
0801050CABBABAB
|
Keytruda | Pembrolizumab | Malignant Disease and Immunosuppression | No data available |
|
Keytruda 50mg pdr for concentrate for inf vials
0801050CABBAAAA
|
Keytruda | Pembrolizumab | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.